Important legal notices
Home Index Introduction Index by contract number Index by coordinator Other information

Dietary caffeine, health and quality of life in Europe
CAFFEINE AND HEALTH

Contract number : QLK1-2000-00069
Contract type : Shared Cost Project
Total cost : € 1.449.042
EC contribution : € 1.449.042
Starting date : 1/01/2001
Duration : 36 Months
Scientific Officer : Rosanna d'Amario
Project website : not yet available
Coordinator
Prof. Dr Jack James
National University of Ireland, Galway
Department of Psychology
University Road
Galway
Ireland
Tel.: +35391512016
Fax: +35391521355
E-mail: j.james @ nuigalway.ie
Background

Although caffeine is consumed daily by more than 300 million EU citizens, its overall impact on quality of life remains unclear. Accordingly, the aim of this project is to characterise the effects of dietary caffeine as consumed in coffee, tea, soft drinks and chocolate. The project, the most comprehensive study of its type undertaken anywhere in the world, brings together a large multidisciplinary team of scientists and consumer organisations. The project will include: (a) basic and applied experimental studies of the effects of caffeine on physiological processes, and physical and mental functions; (b) epidemiological studies of health and well-being in caffeine consumers; and (c) a pan-European programme of information dissemination to consumers, government and industry.

Objectives

The key objective of this project is to characterise the effects of dietary caffeine, as consumed in coffee, tea, soft drinks and chocolate. The project will include: (a) basic and applied experimental studies of the effects of caffeine on physiological processes, and physical and mental functions, and (b) epidemiological studies of health and well-being in caffeine consumers. In addition, the project will include a component aimed specifically at the dissemination of the scientific findings to consumers throughout EU Members States, government and to industry. The general aims of this project are to (a) obtain better understanding of caffeine and its effects; (b) redress major shortfalls in current knowledge regarding the impact of dietary caffeine on the quality of life of EU citizens, especially in relation to health and wellbeing; and (c) disseminate the findings to all relevant interested parties.

(expected) Results and achievements

The project will clarify the implications of dietary caffeine for the health and wellbeing of 300+ million EU citizens who consume caffeine daily. Findings will be published as scientific papers and presented at scientific meetings throughout the 36-month life of the project, and will be disseminated in forms that are accessible and meaningful to all interested parties, including consumers, the public media, relevant health authorities, policy makers, and manufacturers of caffeine products.


Partners

The University of Bristol
Department of Experimental Psychology
8, Woodland Road
BS81TN Bristol
United Kingdom
University Medical Center St. Radboud
Department of Pharmacology and Toxicology
Geert Grooteplein Noord 21
PO Box 9101
6500 HB Nijmegen
The Netherlands
Karolinska Institutet
Department of Physiology and Pharmacology
Karolinska Institutet
171 77 Stockholm
Sweden
Istituto di Ricerche Farmacologiche "Mario Negri"
Laboratory of Epidemiology
Via Eritrea, 62
20157 Milano
Italy
Verbruikersunie Test-Aankoop S.V.
Hollandstraat 13,
1060 Brussel
Belgium


Fifth Framework Programme

PDF Version

:

Volume 1 (PDF 2.9 MB)

   

Volume 2 (PDF 1.9 MB)

 

Last update

:

23-09-2003



[ Index ]    [ Introduction ]    [ Index by contract number ]    [ Index by coordinator ]    [ Others ]